How Neurocrine Biosciences Crushed It in Q2
Neurocrine Biosciences' (NASDAQ: NBIX) 30% plunge earlier this year during the coronavirus-fueled market meltdown is practically all but forgotten now. The stock was up around 15% as of the market close on Monday.
But Neurocrine's shares are now likely to go even higher. The biotech announced its second-quarter results after the market closed on Monday. Here's what you need to know about Neurocrine's impressive Q2 update.
Image source: Getty Images.
Source Fool.com
